CD1d-restricted T Cell Self-antigens and Infection

CD1d 限制性 T 细胞自身抗原与感染

基本信息

  • 批准号:
    7215554
  • 负责人:
  • 金额:
    $ 40.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Natural killer T (NKT) cells recognize CD1d presented lipid antigens. NKT cells have been strongly implicated in host defense to microbial infection due to their ability to rapidly secrete large amounts of cytokines and their influence on the activation of NK cells, macrophages, dendritic cells, B cells and T cells. Except for the striking evidence that aGalCer can pharmacologically activate NKT cells, little is known about the antigens that activate NKT cells physiologically in vivo. Most evidence suggests that CD1d molecules present self-lipid antigens for the development and activation of NKT cells. In mice, self-antigens for Va14 invariant NKT cells are acquired by CD1d molecules that traffic to lysosomes and loading is dependent on saposins. In contrast, the self-antigens for diverse TCR NKT cells may be acquired in the ER. These features are different for human Vot24 invariant NKT cells, as they are stimulated by CD1d molecules that do not traffic through lysosomes and are not saposin dependent. It is assumed that self-antigens are made by CD1d+ ARC and thus are considered endogenous. However, we have now determined that CD1d presented self-lipids also are acquired from extracellular sources where lipids are mainly bound to iipoproteins such as apoE. Thus, we separate endogenous and exogenous pathways of CD1d self-antigen presentation. Here, we propose to identify the self-lipid antigens that bind to CD1d along the secretory route or when trafficking through endosomal compartments and determine which are stimulatory for NKT cells (Aim 1). Because several lines of evidence suggest that important differences exist, we will compare the CD1d selfantigens and their ability to stimulate NKT cells in mice with those in humans (Aim 2). We will then determine the self-antigens acquired by the newly appreciated apoE dependent exogenous pathway (Aim 3). Since lipid and lipoprotein metabolism are changed profoundly in the acute phase reaction during infection, we will determine how endogenously and exogenously acquired CD1d presented self-lipids are altered in inflammation (Aim 4). These studies seek to address the fundamental mechanisms and unanswered questions regarding the self-antigens that activate CD Id-restricted NKT. This has significance for understanding the function of NKT cells and is important for host defense to infection and other diseases.
描述(由申请人提供):自然杀伤T(NKT)细胞识别CD1d呈递的脂质抗原。NKT细胞由于其快速分泌大量细胞因子的能力及其对NK细胞、巨噬细胞、树突细胞、B细胞和T细胞的活化的影响而强烈地参与宿主对微生物感染的防御。除了aGalCer可以间接激活NKT细胞的显著证据之外,关于在体内生理上激活NKT细胞的抗原知之甚少。大多数证据表明,CD1d分子为NKT细胞的发育和活化呈现自身脂质抗原。在小鼠中,Va14不变NKT细胞的自身抗原通过CD1d分子获得,该分子运输到溶酶体并且负载依赖于saposins。相反,不同TCR NKT细胞的自身抗原可在ER中获得。这些特征对于人Vot24不变NKT细胞是不同的,因为它们被不通过溶酶体运输并且不依赖saposin的CD1d分子刺激。假设自身抗原由CD1d+ ARC产生,因此被认为是内源性的。然而,我们现在已经确定,CD1d呈递的自身脂质也是从细胞外来源获得的,其中脂质主要与脂蛋白如apoE结合。因此,我们分离的内源性和外源性途径的CD1d自身抗原呈递。 在这里,我们建议确定自身脂质抗原,结合CD 1d沿着分泌途径或通过内体室运输时,并确定哪些是刺激NKT细胞(目的1)。因为有几条证据表明存在重要的差异,我们将比较CD1d自身抗原及其刺激小鼠和人类NKT细胞的能力(目的2)。然后,我们将确定通过新近认识到的apoE依赖性外源性途径获得的自身抗原(目的3)。由于脂质和脂蛋白代谢在感染期间的急性期反应中发生了深刻的变化,我们将确定内源性和外源性获得的CD1d呈递的自身脂质在炎症中是如何改变的(目的4)。这些研究试图解决关于激活CD Id限制性NKT的自身抗原的基本机制和未回答的问题。这对于理解NKT细胞的功能具有重要意义,并且对于宿主防御感染和其他疾病具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael B. Brenner其他文献

Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
不变自然杀伤 T 细胞:一种与多种效应功能相关的先天性激活方案
  • DOI:
    10.1038/nri3369
  • 发表时间:
    2013-01-21
  • 期刊:
  • 影响因子:
    60.900
  • 作者:
    Patrick J. Brennan;Manfred Brigl;Michael B. Brenner
  • 通讯作者:
    Michael B. Brenner
Adipocyte associated glucocorticoid signaling regulates normal fibroblast function which is lost in inflammatory arthritis
脂肪细胞相关的糖皮质激素信号调节正常成纤维细胞功能,而在炎性关节炎中该功能丧失
  • DOI:
    10.1038/s41467-024-52586-x
  • 发表时间:
    2024-11-14
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Heather J. Faust;Tan-Yun Cheng;Ilya Korsunsky;Gerald F. M. Watts;Shani T. Gal-Oz;William V. Trim;Suppawat Kongthong;Anna Helena Jonsson;Daimon P. Simmons;Fan Zhang;Robert Padera;Susan Chubinskaya;Kevin Wei;Soumya Raychaudhuri;Lydia Lynch;D. Branch Moody;Michael B. Brenner
  • 通讯作者:
    Michael B. Brenner
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin
上皮细胞与 T 淋巴细胞之间通过 E-钙黏蛋白和αEβ7 整合素介导的黏附
  • DOI:
    10.1038/372190a0
  • 发表时间:
    1994-11-10
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Karyn L. Cepek;Sunil K. Shaw;Christina M. Parker;Gary J. Russell;Jon S. Morrow;David L. Rimm;Michael B. Brenner
  • 通讯作者:
    Michael B. Brenner
CD1 antigen presentation: how it works
CD1 抗原呈递:它是如何运作的
  • DOI:
    10.1038/nri2191
  • 发表时间:
    2007-12-01
  • 期刊:
  • 影响因子:
    60.900
  • 作者:
    Duarte C. Barral;Michael B. Brenner
  • 通讯作者:
    Michael B. Brenner
Assembly and retention of CD1b heavy chains in the endoplasmic reticulum.
CD1b 重链在内质网中的组装和保留。
  • DOI:
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Masahiko Sugita;S. Porcelli;Michael B. Brenner
  • 通讯作者:
    Michael B. Brenner

Michael B. Brenner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael B. Brenner', 18)}}的其他基金

CD8 T cell derived Granzyme K activates complement that drives synovial fibroblast inflammation
CD8 T 细胞衍生的颗粒酶 K 激活补体,驱动滑膜成纤维细胞炎症
  • 批准号:
    10733690
  • 财政年份:
    2023
  • 资助金额:
    $ 40.42万
  • 项目类别:
Single cell and spatial genomic analyses of specimens from patients with autoimmune diseases (Technology Core)
自身免疫性疾病患者标本的单细胞和空间基因组分析(技术核心)
  • 批准号:
    10595635
  • 财政年份:
    2022
  • 资助金额:
    $ 40.42万
  • 项目类别:
Single cell and spatial genomic analyses of specimens from patients with autoimmune diseases (Technology Core)
自身免疫性疾病患者标本的单细胞和空间基因组分析(技术核心)
  • 批准号:
    10451924
  • 财政年份:
    2022
  • 资助金额:
    $ 40.42万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10427142
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:
Role of fibroblastic stromal cells and notch signaling in tissue inflammation in RA and SLE
成纤维基质细胞和 Notch 信号在 RA 和 SLE 组织炎症中的作用
  • 批准号:
    10427147
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10088786
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:
Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
RA 和 SLE 炎症组织中免疫细胞和成纤维细胞的分化
  • 批准号:
    10427141
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:
Role of fibroblastic stromal cells and notch signaling in tissue inflammation in RA and SLE
成纤维基质细胞和 Notch 信号在 RA 和 SLE 组织炎症中的作用
  • 批准号:
    10088790
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:
Role of fibroblastic stromal cells and notch signaling in tissue inflammation in RA and SLE
成纤维基质细胞和 Notch 信号在 RA 和 SLE 组织炎症中的作用
  • 批准号:
    10598101
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:
Differentiation of immune cells and fibrobalsts in inflamed tissue in RA and SLE
RA 和 SLE 炎症组织中免疫细胞和成纤维细胞的分化
  • 批准号:
    10598093
  • 财政年份:
    2021
  • 资助金额:
    $ 40.42万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.42万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了